158984-83-9

Basic information

• Product Name: TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE
• Synonyms: TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE;6-HYDROXY-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER;5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate;N-BOC-6-HYDROXY-3,4-DIHYDRO-ISOQUINOLINE;6-hydroxy-2-N-Boc-3,4-dihydroisoquinoline;tert-Butyl 6-hydroxy-1,2,3,4-tetrahydroisoquinoline-2-carboxylate;tert-Butyl 6-hydroxy-3,4-dihydro-2(1H)-isoquinolinecarboxylate;2-N-Boc-6-Hydroxy-3,4-dihydroisoquinoline
• CAS NO: 158984-83-9
• Molecular Formula: C₁₄H₁₉NO₃
• Molecular Weight: 249.31
• Mol File: 158984-83-9.mol
• Article Data: 43

Chemical Properties

• Melting Point: 110-111.5 °C
• Boiling Point: 391.376 °C at 760 mmHg
• Flash Point: 190.497 °C
• Appearance: /
• Density: 1.171 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: 2-8°C
• PKA: 9.79±0.20(Predicted)
• CAS DataBase Reference: TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE(158984-83-9)
• EPA Substance Registry System: TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE(158984-83-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 158984-83-9(Hazardous Substances Data)

Usage

Description

tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate is an organic compound that serves as a key intermediate in the synthesis of various pharmaceuticals, particularly androgen receptor modulators. It is characterized by its unique chemical structure, which allows it to participate in a range of chemical reactions and contribute to the development of therapeutic agents.

Uses

Used in Pharmaceutical Industry:
tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate is used as a chemical reagent for the synthesis of androgen receptor modulators. Its role in the pharmaceutical industry is crucial, as it aids in the development of medications that can potentially treat various conditions related to androgen receptors, such as hormonal imbalances and certain types of cancer.
Used in Research and Development:
In addition to its application in the pharmaceutical industry, tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate is also utilized in research and development settings. Scientists and researchers employ this compound to study the mechanisms of androgen receptor modulators and to develop new drugs with improved efficacy and safety profiles.

InChI:InChI=1/C14H19NO3/c1-14(2,3)18-13(17)15-7-6-10-8-12(16)5-4-11(10)9-15/h4-5,8,16H,6-7,9H2,1-3H3

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 59839-23-5 6-hydroxy-1,2,3,4-tetrahydroisoquinoline hydrobromide 
• 63905-73-7 6-hydroxy-1,2,3,4-tetrahydroisoquinoline hydrochloride 
• 188576-49-0 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid tert-butyl ester 
• 14446-24-3 6-hydroxy-1,2,3,4-tetrahydroisoquinoline 
• 110-89-4 piperidine 
• 110339-52-1 C₁₀H₁₃NO 
• 22246-12-4 6-methoxy-1,2,3,4-tetrahydro-1-oxoisoquinoline 
• 591-31-1 3-methoxy-benzaldehyde 
• 3179-09-7 1-methoxy-3-(2-nitrovinyl)benzene 
• 2039-67-0 2-(3-methoxyphenyl)-1-ethanamine 
• 57196-62-0 6-methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride 
• 942150-85-8 bis(6-methoxy-N-1,2,3,4-tetrahydroisoquinolinyl)methane 
• 110192-21-7 N-(methoxycarbonyl)-2-(3'-methoxyphenyl)ethylamine 

Downstream Products

• 158984-84-0 6-trifluoromethanesulfonyloxy-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 170097-66-2 3,4-Dihydro-1H-isoquinoline-2.6-dicarboxylic acid 2-tert-butyl ester-6-methyl ester 
• 170097-67-3 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid 
• 166398-33-0 tert-butyl 6-cyano-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 1046816-76-5 tert-butyl 6-(3-(4-(5-ethylpyrimidin-2-yl)phenyl)propoxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 893566-72-8 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 1266120-56-2 6-(4-tert-butyl-cyclohexyloxy)-1,2,3,4-tetrahydro-isoquinoline hydrochloride 
• 1266120-58-4 3-tert-butoxycarbonylamino-4-[6-(4-tert-butyl-cyclohexyloxy)-3,4-dihydro-1H-isoquinolin-2-yl]-4-oxo-butyric acid tert-butyl ester 
• 1266120-54-0 6-(4-tert-butyl-cyclohexyloxy)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 164148-88-3 6-benzyloxy-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 1429253-97-3 C₂₈H₂₆N₄O₂ 
• 1429254-04-5 C₂₄H₂₅N₃O₃ 
• 630407-52-2 6-ethoxy-1,2,3,4-tetrahydro-isoquinoline 
• 252061-94-2 6-benzyloxy-1,2,3,4-tetrahydro-isoquinoline 

Relevant articles and documents

An improved procedure for the cyanation of aryl triflates: A convenient synthesis of 6-cyano-1,2,3,4-tetrahydroisoquinoline

A short synthesis of 6-cyano-1,2,3,4-tetrahydroisoquinoline is presented. The key step is an improved method of aryl triflate cyanation employing zinc(II)cyanide as the cyanide source.

MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION

Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated

Azacyclic derivative as well as preparation method and medical use thereof

The invention relates to an azacyclic derivative as well as a preparation method and medical use thereof and particularly relates to an azacyclic derivative represented by a general formula (I) (shownin the description), a preparation method thereof, a pharmaceutical composition containing the derivative and use of the derivative as an SMO antagonist, particularly in the treatment of diseases such as cancer related to Hedgehog signal channels. The definitions of groups in the general formula (I) are same as the definitions in the description.